Literature DB >> 24049171

Aged mice exhibit a severely diminished CD8 T cell response following respiratory syncytial virus infection.

Ross B Fulton1, Kayla A Weiss, Lecia L Pewe, John T Harty, Steven M Varga.   

Abstract

Respiratory virus infections in the elderly result in increased rates of hospitalization and death. Respiratory syncytial virus (RSV) is a leading cause of severe virus-induced respiratory disease in individuals over the age of 65. CD8 T cells play a critical role in mediating RSV clearance. While it is clear that T cell immunity declines with age, it is not clear to what extent the CD8 T cell response to RSV is altered. Using aged BALB/c mice, we demonstrated that RSV-specific CD8 T cell responses were significantly reduced in the lungs of aged mice at the peak of the T cell response and that this decrease correlated with delayed viral clearance. Despite a decrease in the overall numbers of RSV-specific CD8 T cells during acute infection, their capacity to produce effector cytokines was not impaired. Following viral clearance, the RSV-specific memory CD8 T cells were similar in total number and phenotype in young and aged mice. Furthermore, following infection with a heterologous pathogen expressing an RSV epitope, RSV-specific memory CD8 T cells exhibited similar activation and ability to provide early control of the infection in young and aged mice. These data demonstrate a decrease in the capacity of aged mice to induce a high-magnitude acute CD8 T cell response, leading to prolonged viral replication, which may contribute to the increased disease severity of RSV infection observed for aged individuals.

Entities:  

Mesh:

Year:  2013        PMID: 24049171      PMCID: PMC3838124          DOI: 10.1128/JVI.02282-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  Age-related changes in lymphocyte development and function.

Authors:  Phyllis Jean Linton; Kenneth Dorshkind
Journal:  Nat Immunol       Date:  2004-02       Impact factor: 25.606

2.  Pgp-1hi T lymphocytes accumulate with age in mice and respond poorly to concanavalin A.

Authors:  A Lerner; T Yamada; R A Miller
Journal:  Eur J Immunol       Date:  1989-06       Impact factor: 5.532

3.  Effects of aging on the adaptive immune response to respiratory virus infections.

Authors:  Ross B Fulton; Steven M Varga
Journal:  Aging health       Date:  2009-12-01

Review 4.  T-cell quality in memory and protection: implications for vaccine design.

Authors:  Robert A Seder; Patricia A Darrah; Mario Roederer
Journal:  Nat Rev Immunol       Date:  2008-03-07       Impact factor: 53.106

5.  Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice.

Authors:  Jincun Zhao; Jingxian Zhao; Kevin Legge; Stanley Perlman
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

6.  Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects.

Authors:  R Hingorani; I H Choi; P Akolkar; B Gulwani-Akolkar; R Pergolizzi; J Silver; P K Gregersen
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

7.  Unexpected expansions of CD8-bearing cells in old mice.

Authors:  J E Callahan; J W Kappler; P Marrack
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

8.  An aged mouse model for RSV infection and diminished CD8(+) CTL responses.

Authors:  Yongxin Zhang; Ying Wang; Xyanthine Gilmore; Keyi Xu; Philip R Wyde; Innocent N Mbawuike
Journal:  Exp Biol Med (Maywood)       Date:  2002-02

9.  CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly.

Authors:  Laura Haynes; Sheri M Eaton; Eve M Burns; Troy D Randall; Susan L Swain
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

Review 10.  T-cell immunosenescence: lessons learned from mouse models of aging.

Authors:  Alexander C Maue; Eric J Yager; Susan L Swain; David L Woodland; Marcia A Blackman; Laura Haynes
Journal:  Trends Immunol       Date:  2009-06-21       Impact factor: 16.687

View more
  12 in total

1.  Respiratory Syncytial Virus Provides Protection against a Subsequent Influenza A Virus Infection.

Authors:  Stacey M Hartwig; Ann M Miller; Steven M Varga
Journal:  J Immunol       Date:  2022-01-12       Impact factor: 5.422

2.  Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8+ T-cell immunity against respiratory syncytial virus infection.

Authors:  Jeong-Yoon Lee; Jun Chang
Journal:  J Microbiol       Date:  2017-10-27       Impact factor: 3.422

Review 3.  Nanoparticle vaccines against respiratory syncytial virus.

Authors:  Laura M Stephens; Steven M Varga
Journal:  Future Virol       Date:  2020-11-30       Impact factor: 1.831

4.  Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice.

Authors:  Corinne Cayatte; Angie Snell Bennett; Gaurav Manohar Rajani; Leigh Hostetler; Sean K Maynard; Michelle Lazzaro; Patrick McTamney; Kuishu Ren; Terrence O'Day; Michael P McCarthy; Kirsten Schneider-Ohrum
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

5.  Transcriptomics in lung tissue upon respiratory syncytial virus infection reveals aging as important modulator of immune activation and matrix maintenance.

Authors:  Jeroen L A Pennings; Rob Mariman; Hennie M Hodemaekers; Sylvia S N Reemers; Riny Janssen; Teun Guichelaar
Journal:  Sci Rep       Date:  2018-11-09       Impact factor: 4.379

6.  Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability.

Authors:  J Lederhofer; J van Lent; F Bhoelan; Z Karneva; A de Haan; J C Wilschut; T Stegmann
Journal:  Pharm Res       Date:  2018-07-03       Impact factor: 4.200

Review 7.  Small Animal Models of Respiratory Viral Infection Related to Asthma.

Authors:  Mingyuan Han; Charu Rajput; Tomoko Ishikawa; Caitlin R Jarman; Julie Lee; Marc B Hershenson
Journal:  Viruses       Date:  2018-12-01       Impact factor: 5.048

Review 8.  The aging lung: Physiology, disease, and immunity.

Authors:  Jaime L Schneider; Jared H Rowe; Carolina Garcia-de-Alba; Carla F Kim; Arlene H Sharpe; Marcia C Haigis
Journal:  Cell       Date:  2021-04-02       Impact factor: 66.850

Review 9.  Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population.

Authors:  Laura M Stephens; Steven M Varga
Journal:  Vaccines (Basel)       Date:  2021-06-09

Review 10.  Cytokines and CD8 T cell immunity during respiratory syncytial virus infection.

Authors:  Megan E Schmidt; Steven M Varga
Journal:  Cytokine       Date:  2018-07-18       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.